Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole

Abstract

Gynecomastia is an unusual side effect associated with testosterone replacement therapy (TRT) that has been traditionally treated with surgery, radiation, or discontinuation of testosterone supplementation. We report here our experience with two cases of gynecomastia in men undergoing TRT who were successfully treated with the aromatase inhibitor anastrozole.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Taplin ME, Ho S-M . The endocrinology of prostate cancer. J Clin Endocrinol Metab 2001; 86: 3467–3477.

    Article  CAS  Google Scholar 

  2. Gruntmanis U, Braunstein GD . Treatment of gynecomastia. Curr Opin Invest Drugs 2001; 2: 643–649.

    CAS  Google Scholar 

  3. Raman JD, Schlegel PN . Aromatase inhibitors for male infertility. J Urol 2002; 167: 624–629.

    Article  CAS  Google Scholar 

  4. Geisler J et al. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor on in vivo aromatization and plasma estrogen levels in postmenopausal women with breast cancer. Br J Cancer 1996; 74: 1286.

    Article  CAS  Google Scholar 

  5. Buzdar AU, Riobertson JFR, Eliermann W, Nabholtz J-M . An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Pharmacol Pharmacokinet 2002; 95: 2006–2016.

    CAS  Google Scholar 

  6. Gillam MP, Middler S, Freed DJ, Molitch ME . The novel use of very high doses of cabergoline and combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 2002; 87: 4447–4451.

    Article  CAS  Google Scholar 

  7. Herzog AG, Klein P, Jacobs AR . Testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy in men with epilepsy and hypogonadism. Neurology 1998; 50: 782–784.

    Article  CAS  Google Scholar 

  8. Taxel P et al. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J Clin Endocrinol Metab 2001; 86: 2869–2874.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to E L Rhoden or A Morgentaler.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rhoden, E., Morgentaler, A. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int J Impot Res 16, 95–97 (2004). https://doi.org/10.1038/sj.ijir.3901154

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901154

Keywords

This article is cited by

Search

Quick links